Fluicell AB (publ)

kr 28.00As of Sun 8 Nov 2026, 12:00 UTC
STO:FLUIHealthcare
Country Sweden
PE (Fwd) •••
TSR 9Y CAGR (44.49%)
Div yield —
ROE 18.58%
Biotechnology
Beta (5Y) 2.15
PE TTM 13.77
TSR TTM 113.74%
Mkt cap kr 38.46M
ROIC 10.13%
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 29
3.11%
21.28%
Hold 8|5|1|4|1
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.44
0.47
0.51
0.57
(5.11%)
6.04%
16.32%
30.45%
Revenuekr M
2.111
2.054
2.068
2.085
0.57%
(1.24%)
(5.25%)
(2.62%)
Peers (US$3.889M)
Cap (US$)
PE
5.651M
1.763x
3.597M
—
Capital
TTM
5Y
10Y
Leveragex
0.938
3.838
3.467
EBIT/Intx
0.578
0.754
0.781
Own earn%
68.97
17.81
2.24
Sh yield%
22.78
47.95
49.10
Owners
Insiders/Inst%
4.82
73.46
Short interest%
4.86
SBC / revenue%
2.10
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
24–28
$1 testx
—
Incr. ROIC%
3